CN110849863A - Method for rapidly and effectively detecting conformational change in binding process of aptamer and ligand small molecule - Google Patents

Method for rapidly and effectively detecting conformational change in binding process of aptamer and ligand small molecule Download PDF

Info

Publication number
CN110849863A
CN110849863A CN201910978373.9A CN201910978373A CN110849863A CN 110849863 A CN110849863 A CN 110849863A CN 201910978373 A CN201910978373 A CN 201910978373A CN 110849863 A CN110849863 A CN 110849863A
Authority
CN
China
Prior art keywords
aptamer
ligand
solution
theophylline
small molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201910978373.9A
Other languages
Chinese (zh)
Other versions
CN110849863B (en
Inventor
陆峰
崔晓林
柳艳
袁一凡
王梁华
柴逸峰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Second Military Medical University SMMU
Original Assignee
Second Military Medical University SMMU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Second Military Medical University SMMU filed Critical Second Military Medical University SMMU
Priority to CN201910978373.9A priority Critical patent/CN110849863B/en
Publication of CN110849863A publication Critical patent/CN110849863A/en
Application granted granted Critical
Publication of CN110849863B publication Critical patent/CN110849863B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/65Raman scattering
    • G01N21/658Raman scattering enhancement Raman, e.g. surface plasmons

Landscapes

  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention relates to the technical field of biological medicines, in particular to a method for quickly and effectively detecting conformational change in the process of combining an aptamer and a ligand small molecule, which comprises the following steps: firstly, determining the affinity between the selected aptamer and the small molecule by using a biological membrane interference experiment; then detecting the conformational change before and after the aptamer is combined with the small molecule by using a surface enhanced Raman scattering spectroscopy technology; and finally, intuitively explaining the binding process of the aptamer and the ligand through molecular dynamics simulation. The invention takes theophylline and an aptamer thereof as an example, verifies the reliability of the method for researching the conformation change of the aptamer, provides a new method and a new thought for designing, modifying and screening the aptamer with high affinity and high selectivity, and leads the aptamer to be better applied to the fields of detection, sensing, clinical diagnosis, treatment and the like.

Description

Method for rapidly and effectively detecting conformational change in binding process of aptamer and ligand small molecule
Technical Field
The invention relates to the technical field of biological medicines, in particular to a method for quickly and effectively detecting conformation change in the process of combining an aptamer and a ligand small molecule.
Background
The aptamer is usually an oligonucleotide sequence screened from a gene library by SELEX (Systematic evolution of Ligands by expression) technology. It can be conjugated to corresponding target molecules such as: drugs, proteins, nucleic acids or other inorganic, organic molecules, etc. are bound with high affinity and strong specificity. Meanwhile, the aptamer has the advantages of thermal stability, salt tolerance, easiness in synthesis, low cost and the like, so that the aptamer gradually becomes a hotspot of research in the fields of Detection, sensing, clinic and the like (Negri, P.; Chen, G.; Kage, A.; Nitsche, A.; Naumann, D.; Xu, B.; Dluhy, R.A., Direct Optical Detection of visual nucleic acid binding an-Influenza aptamer. analytical Chemistry 2012,84,5501 5508). Therefore, the research on the conformation change in the process of combining the aptamer and the small molecule has important significance for designing, modifying and screening the aptamer with high affinity and high selectivity.
Many researchers have shown strong interest in aptamer conformation changes, but most studies have used electrochemical methods to verify aptamer binding to ligand molecules, which is time consuming, requires large sample volumes and is complicated to operate. Therefore, it is urgently needed to establish a rapid, simple and nondestructive method for confirming, detecting and mechanistically explaining the change of aptamer conformation.
BLI (biofilm interference) technology is a non-labeling means based on the principle of light interference, has the advantages of simple operation, nondestructive detection, low sample consumption, capability of providing direct information and interaction condition of analytes in real time and the like, and is widely applied to the research of interaction of biomolecules (Gao, S.; Hu, B.; Zheng, X.; Cao, Y.; Liu, D.; Sun, M.; Jiano, B.; Wang, L., Gonyauutoxin 1/4 interaction with high-affinity and specificity: From interference selection to interaction utilization, biosensors and Bioelectronics 2016,79,938 and 944.). The BLI technique not only allows rapid analysis of the binding of the supplied ligand to the aptamer, but also gives an accurate value of the affinity of the two. However, the conformational change of the aptamer upon binding to the ligand molecule cannot be detected, and therefore, the conformational change of the aptamer needs to be detected by other means.
The SERS (surface-enhanced Raman spectroscopy) technique has attracted much attention because of its advantages of high sensitivity, abundant characteristic information, and fast detection speed. The kit can provide a detailed fingerprint map of a substance to be detected, and is a powerful tool for detecting molecules such as nucleic acid, protein, cells, viruses and medicines (Morla-Folch, J.; Gisbert-Quilis, P.; Masetti, M.; Garcia-Rico, E.; Alvarez-Puebla, R.A.; Guerrii, L., structural SERS Classification of K-Ras Point Mutations for cancer diagnostics, Angewandte Chemie 2017,129, 2421-. The weak interaction between molecules can be reflected on the SERS spectrum, so that the conformation change of the aptamer and the ligand molecule after combination can be directly judged. Changes in the SERS spectrum may be attributed to changes caused by which base on the aptamer. However, since the change of the SERS spectrum is also an indirect indicator, how the conformation is changed in particular needs to be further explained by other means.
The MD (molecular dynamics) simulation refers to simulating the movement locus of a molecular system over time by using computer software and taking atoms as basic elements and solving the position and speed of each particle in the system at a certain moment under the action of an empirical potential field according to the newton mechanics principle. MD simulations can simulate the conditions controlled in biological experiments, such as temperature, pressure, ion concentration, pH, and solvent type. All these factors can be adjusted and controlled in the MD simulation (conveyer, J.et. the impact of molecular dynamics on drug design: application for the characterization of the characteristics of the ligand-macro modules. drug discovery, 2015.20(6): p.686-702.). The method can accurately predict the binding mode and binding capacity of the aptamer and the ligand molecule, and the result can be used for guiding experiments, providing thought and theoretical basis and making up the limitation of experimental means such as spectrum and the like.
However, no report is available about a method for rapidly and effectively detecting the conformational change in the process of binding the aptamer and the ligand small molecule by a sequential analysis mode of a biological membrane interference experiment, a surface enhanced raman spectroscopy technology and molecular dynamics simulation.
Disclosure of Invention
The invention aims to provide a method for rapidly and effectively detecting the conformational change in the process of combining an aptamer and a ligand small molecule. The invention takes theophylline micromolecules and aptamers thereof as examples, researches the change of conformations before and after the binding of the aptamers and the theophylline through a step-by-step analysis mode of biomembrane interference experiment, surface enhanced Raman spectroscopy technology and molecular dynamics simulation, provides a new scheme for designing, screening and modifying the aptamers with high affinity and high selectivity, and can be better applied to the fields of detection, sensing, clinical diagnosis, treatment and the like.
In order to achieve the purpose, the technical scheme of the invention is as follows: firstly, the affinity between the selected aptamer and the ligand molecule is measured by utilizing a BLI (biofilm interference) technology, after the two are determined to be capable of being combined, the conformation change before and after the aptamer is combined with the small molecule is detected by utilizing an SERS (surface-enhanced Raman spectroscopy) method, the spectrogram of the aptamer before and after the aptamer is combined with the small molecule is directly collected, and the conformation change of the aptamer and the reason of the change caused by attribution are determined according to the change before and after the SERS spectrogram. Finally, the binding process of the aptamer and the ligand is intuitively explained by using an MD (molecular dynamics) simulation means, and the spatial change condition of the aptamer in the binding process is deeply analyzed, so that the conformational change of the aptamer can be comprehensively and deeply understood, and the reason for causing the conformational change can be explained.
The invention takes theophylline small molecules and aptamers thereof as examples, and verifies the feasibility and superiority of a step-by-step analysis method of biomembrane interference-surface enhanced Raman spectroscopy-molecular dynamics simulation (BLI-SERS-MD, the principle is shown in figure 1) on researching the conformational change of the aptamers in the binding process.
Theophylline is a methylpurine medicine and is clinically used for treating diseases such as asthma, emphysema and bronchitis. Due to the narrow treatment window (20-100 mu M), the blood concentration of the medicine needs to be monitored during clinical treatment. The blood concentration of the aptamer is measured by a conventional aptamer capturing mode, the specificity is good, the selectivity is high, and the interference of caffeine, theobromine and the like is well eliminated. Therefore, the research on the conformational change in the binding process of the aptamer and theophylline has important significance for designing and modifying an aptamer which has higher affinity and better binding specificity with theophylline. The same technique can also be applied to the analysis of the conformational changes of other ligands and their aptamers.
In a first aspect of the present invention, a method for rapidly and effectively detecting a conformational change during the binding of an aptamer and a small ligand molecule is provided, which comprises the following steps:
the method comprises the following steps: measuring the affinity between the selected aptamer and the ligand molecule by using a biofilm interference (BLI) technology;
step two: the method comprises the following steps of weakly combining an aptamer on a surface-enhanced Raman spectroscopy (SERS for short) substrate by utilizing a SERS technology, collecting spectrograms of the aptamer before and after the aptamer is combined with a ligand small molecule, and determining the change of aptamer conformation and the reason of change caused by attribution according to the change of the SERS spectrogram before and after;
step three: the method comprises the steps of simulating a dynamic process of combining a ligand and an aptamer by using a Molecular Dynamics (MD) simulation means, calculating a motion correlation coefficient of the aptamer and a main group on the ligand, analyzing the space change condition of the aptamer in the combining process, and explaining the cause of conformational change.
Further, the first step is:
firstly, a ligand solution and an aptamer solution are respectively prepared by using buffer solution, then after 200 μ L of each prepared aptamer solution, ligand solution and buffer solution are respectively added into each reaction hole (OctetRED 96, ForteBio company), a chip connected with streptomycin is sequentially immersed into each reaction hole according to a set program, and five stages are carried out in total, wherein each stage takes 60s, and the method comprises the following steps: baseline equilibration, aptamer coupling, sensor equilibration, binding and dissociation, and then the aptamer-ligand affinity constants.
Further, in the second step, in the method for preparing the SERS substrate:
firstly, preparing a silver colloid solution by a Lee method, and then concentrating the obtained silver colloid solution by a method of centrifuging and removing supernatant fluid by about 60 times; adding 5 mu L of 1mM KI solution into 10 mu L of the concentrated silver colloid solution; to the solution was added 4. mu.L of 10mM MgSO4And (3) solution.
Further, the method for preparing the silver colloid solution by the Lee method comprises the following steps: 36mg of silver nitrate powder is dissolved in 200mL of deionized water, heated and stirred continuously until the solution boils slightly, then 4mL of 1% sodium citrate solution is added, the heating and stirring are continued for about 1h, the solution changes from colorless to grayish green, the heating is stopped, the solution is cooled to room temperature and stored in the dark (reference Lee, P.C.; Meisel, D.Adsorption and surface-enhanced Raman of dye on silver and gold solvents, the Journal of Physical Chemistry 1982,86,3391 and 3395.).
Furthermore, in the second step,
after the aptamer is weakly bonded to the surface of the silver colloid, adding a ligand solution in an equal proportion, adding deionized water into the mixed aptamer-ligand solution, diluting to 100 mu L, and transferring to a 96-well plate to collect SERS signals; the final detection concentration of the substance to be detected was 10. mu.M.
Further, in the third step, the method for simulating the dynamic process of the ligand binding to the aptamer comprises:
firstly, establishing initialization of a simulation system; placing the ligand and aptamer system in a water box with a proper size, selecting SPC/E as a water model, and then carrying out ionization treatment on the system; the force field parameter file of the ligand is generated by AmberTools; then, carrying out energy minimization and balance simulation on the system; the energy minimization uses a steepest descent algorithm, and the simulation is carried out for 500steps under the condition of no constraint; the equilibrium simulation is divided into two steps: the temperature of the system is controlled to be increased from 0K to 300K in the first step, 10000steps are simulated in operation under the constraint condition, the temperature of the system is maintained to be 300K in the second step, and 10000steps are simulated in operation under the constraint condition; finally, simulating 95ns (step length is 2fs) by using the balanced system under the NPT ensemble; controlling the pressure to be 1.01atm and the temperature to be 310K; meanwhile, calculating the RMSD value (root-mean-square deviation) of the aptamer-ligand molecule complex system along with the change of time to estimate the change degree of the conformation before and after the combination of the aptamer-ligand molecule complex system and the ligand molecule complex system; the conformational change process is analyzed by intercepting conformational states of several different frames.
Further, in the third step, the method for calculating the motion correlation coefficient between the aptamer and the main group on the ligand comprises:
adopting gromacs to obtain a PDB file of each frame; respectively reading PDB files of each frame and the mass center coordinate of the next frame, and subtracting the mass center coordinate of the previous frame from the mass center coordinate of the next frame of each nucleotide or theophylline to obtain a movement vector of the mass center coordinate of each frame; then, acquiring a micromolecule centroid coordinate movement vector and a correlation coefficient (Pearson product moment correlation coefficient) of each nucleotide centroid coordinate movement vector by using a numpy. And averaging the motion correlation coefficient of each nucleotide and the small molecule in all the adjacent frames to obtain the average motion correlation coefficient.
Further, the ligand is theophylline, and the aptamer is an RNA sequence shown as SEQ ID NO. 1.
Further, the first step is: buffer (Tris-HCl buffer +10mM MgSO)4pH 7.4) to prepare 10 mu M theophylline solution and 500nM aptamer RNA (5' end is connected with biotin) solution, wherein all RNA solutions are prepared at present and stored in an ice box to prevent degradation; then, after the prepared aptamer solution and 200 μ L of theophylline are respectively added into each reaction hole, the chip connected with streptomycin is sequentially immersed into each reaction hole according to a set program, and five stages are carried out, wherein each stage takes 60s, and the method comprises the following steps: baseline balance, aptamer coupling, sensor balance, binding and dissociation; then the response value of the aptamer-theophylline can be obtained.
The present invention selects a reported oneThe RNA sequence with high affinity with theophylline is used as an aptamer (5'-GGCGAUACCAGCCGAAAGGCCCUUGGCAGCGUC-3', SEQ ID NO.1), the affinity of the RNA sequence and the aptamer is verified by utilizing the BLI technology, and a specific affinity value (K) is obtainedd=1.29μM)。
Furthermore, the second step is: first, a silver colloid solution was prepared by Lee method, and the obtained silver colloid solution was concentrated by 60 times by centrifugation and supernatant removal, 5. mu.L of 1mM KI solution was added to 10. mu.L of the concentrated silver colloid solution, and 4. mu.L of 10mM MgSO 2 was added to the solution4A solution; after the aptamer is weakly combined on the surface of the silver colloid, 100 mu M theophylline solution is added in an equal ratio; adding deionized water into the mixed aptamer-theophylline solution, diluting to 100 mu L, and transferring to a 96-well plate to collect SERS signals; the final detection concentration of the substance to be detected is 10 mu M; SERS detection conditions: all spectra were obtained from a BWS415Raman spectrometer (B)&W Tek, USA), the excitation wavelength is 785nm, the laser power is 100mW, and the integration time is 10 s.
The invention provides the change of an SERS spectrogram caused by the change of aptamer conformation due to the entry of theophylline after the aptamer is combined with the theophylline. The existence of interaction between the two is directly proved, and the base species causing the conformational change can be assigned through the changed peak displacement in the SERS spectrogram.
Furthermore, the third step is:
(A) dynamic process of combining MD simulation theophylline and aptamer
Firstly, establishing initialization of a simulation system; placing the theophylline and aptamer system in a water box with proper size (the distance from the surface of the compound to the boundary of the water box is
Figure BDA0002234382890000061
) Selecting SPC/E as a water model, and then carrying out ionization treatment on the system; the force field parameter file of theophylline is generated by AmberTools; then, carrying out energy minimization and balance simulation on the system; the energy minimization uses a steepest descent algorithm, and the simulation is carried out for 500steps under the condition of no constraint; the equilibrium simulation is divided into two steps: the first step is to control the temperature of the system fromHeating 0K to 300K, operating and simulating 10000steps under the constraint condition, maintaining the system temperature at 300K in the second step, and operating and simulating 10000steps under the constraint condition; finally, simulating 95ns (step length is 2fs) by using the balanced system under the NPT ensemble; controlling the pressure to be 1.01atm and the temperature to be 310K; calculating the RMSD value (root-mean-square deviation) of the aptamer-theophylline molecular complex system along with the change of time to estimate the change degree of the conformation before and after the combination of the aptamer-theophylline molecular complex system and the theophylline molecular complex system; intercepting the conformational states of a plurality of different frames, and analyzing the conformational change process;
(B) calculating the motion correlation coefficient of the aptamer and the main group on theophylline
Adopting gromacs to obtain a PDB file of each frame; respectively reading PDB files of each frame and the mass center coordinate of the next frame, and subtracting the mass center coordinate of the previous frame from the mass center coordinate of the next frame of each nucleotide or theophylline to obtain a movement vector of the mass center coordinate of each frame; then, acquiring a micromolecule centroid coordinate movement vector and a correlation coefficient (Pearson product moment correlation coefficient) of each nucleotide centroid coordinate movement vector by using a numpy. Averaging the motion correlation coefficients of each nucleotide and the small molecules in all adjacent frames to obtain an average motion correlation coefficient; the motion correlation coefficients of 33 bases on the aptamer and N-1, N-3, N-7, N-9, C ═ O-2, C ═ O-6, CH3-1, CH3-3, the pyrimidine ring and the imidazole ring on theophylline are calculated respectively, and the closer the motion correlation coefficient is to 1, the closer the motion correlation coefficient is, the closer the motion correlation between the two is, the certain interaction can exist.
The invention simulates the dynamic process of combining the aptamer and theophylline and deeply explains the change of the aptamer. By performing MD simulation on the aptamer and theophylline, the binding mode and the binding capacity of the theophylline and the aptamer can be obtained, and a series of changes of the aptamer conformation can be visually and dynamically displayed. In combination with the above experimental results, we can have a thorough understanding of the conformational changes of aptamers.
The invention has the advantages that:
1. compared with the traditional method for analyzing the conformational change of the aptamer by only one method, the method for analyzing the conformational change step by step can comprehensively analyze, confirm and explain the mechanism of the conformational change;
2. the three selected BLI-SERS-MD technical means do not need complex operation, the required amount of samples is small, and the cost is low;
3. although the three methods are a gradual and deep process for researching the conformation of the aptamer, the instruments work independently without interference and can be carried out simultaneously, and the time is greatly saved.
Drawings
FIG. 1 is a schematic view of the principle
FIG. 2 shows the binding dissociation curves of aptamer RNA and negative control NC with theophylline, respectively.
FIG. 3.a SERS spectrum of theophylline; b, SERS spectrogram of aptamer RNA; c SERS spectrogram of theophylline-aptamer complex; d difference spectrum (c-b).
FIG. 4.a SERS spectra of negative control NC; b, SERS spectrogram of aptamer RNA; c, SERS spectrogram of theophylline; d SERS spectrogram of NC; SERS spectrogram of the e theophylline-NC mixture; f difference spectrum (e-d).
FIG. 5 shows the process of conformational change of aptamer binding to theophylline.
FIG. 6 is a kinetic correlation coefficient of 33 bases on aptamer RNA with the main atom or group on theophylline.
Detailed Description
The following examples are provided to illustrate specific embodiments of the present invention. The following examples are carried out on the premise of the technical scheme of the present invention, and detailed embodiments are given, but the scope of the present invention is not limited to the following examples, and reagents used are commercially available unless otherwise specified.
Example 1: determination of affinity between small molecules of theophylline and its aptamer RNA by BLI
The affinity between theophylline small molecule and its aptamer is determined by BLI technique, and at the same time, one RNA sequence (NC: UUGUACUACACAAAAGUACUG, SEQ ID NO.2) with 21 bases is randomly selected as negative control to react with theophylline, and its affinity constant K is determined under the same condition as that of aptamerdThe value is obtained.
First, buffer (Tris-HCl buffer +10mM MgSO)4pH 7.4) to prepare 10 mu M theophylline solution, 500nM aptamer RNA (5 'end is connected with biotin) solution and 500nM NC (5' end is connected with biotin) solution respectively, wherein all the RNA solutions are prepared at present and stored in an ice box to prevent degradation. Then adding 200 mul of prepared aptamer solution, NC solution, theophylline and buffer solution into each reaction hole respectively, and then sequentially immersing the chip connected with the streptomycin into each reaction hole according to a set program, wherein the total time of five stages is 60s, and the steps comprise: baseline balance, aptamer coupling, sensor balance, binding and dissociation. Then response values of the aptamer-theophylline and NC-theophylline can be obtained. The results are shown in FIG. 2. The binding-dissociation curve of the aptamer and the theophylline is a process of rapid rising and rapid falling, because the molecular weight of the theophylline is too small, the affinity with the aptamer is high, and the binding process and the dissociation process can quickly reach equilibrium. The combination-dissociation curve of NC and theophylline is almost a straight line, which indicates that no affinity exists between the randomly selected nucleic acid sequence and theophylline, namely NC does not interact with theophylline. We obtained the affinity constant K of the theophylline-aptamerd1.29 μ M, while the theophylline-NC affinity constant is almost zero.
Example 2: weak binding of aptamer RNA to SERS substrates
Firstly, a silver colloid solution is prepared by a Lee method (Lee, P.C.; Meisel, D.Adorption and surface-enhanced Raman of dyes on silver and gold gases, the Journal of Physical Chemistry 1982,86,3391-3395.) and the obtained silver colloid solution is concentrated by a method of centrifuging and removing supernatant fluid by about 60 times so as to enhance the Raman signal of a substance to be detected. However, while the silver colloid is concentrated, impurities on the surfaces of silver nano particles (AgNPs) are also enriched, and strong Raman signals are shown and even exceed the signals of substances to be detected. Therefore, we added 5 μ L of 1mM KI solution to 10 μ L of the concentrated silver colloid solution for washing the citrate ions on the surface of the silver nanoparticles and making the surface of the silver nanoparticles strongly negatively charged (AgNP-I)-). However, the aptamer RNA of the substance to be detected is abundant due to the existence of the chain skeletonThe phosphate group of (a), also renders the entire molecule electronegative. The strong electrostatic repulsion causes the aptamer RNA to fail to reach the surface of the silver colloid. To eliminate this blockage, we added 4. mu.L of 10mM MgSO to the solution4And (3) solution. Mg (magnesium)2+Not only plays a role of connecting the aptamer and the silver nano-particles, but also promotes the combination of the aptamer and theophylline (AgNP-I)--Mg2+-PO2-). At the moment, the aptamer RNA and the silver nanoparticles are weakly combined together through electrostatic interaction, so that the purpose of shortening the distance between the aptamer RNA and the silver nanoparticles is achieved, a higher detection signal is obtained, and the situation that the aptamer is directly fixed on the surface of the silver colloid through a linker such as polysaccharide or alkanethiol and the like to limit the space extensibility and flexibility of the aptamer is avoided.
Example 3: changes in SERS spectra before and after aptamer binding to theophylline
After the aptamers were weakly bound to the surface of the silver colloid, 100 μ M theophylline solution was added at equal ratio. In the presence of Mg2+The theophylline and the aptamer are mutually induced and combined, and the theophylline molecule has small mass and volume compared with the aptamer, so that the conformation of the theophylline molecule is unchanged in the combination process of the theophylline molecule and the aptamer, the conformation of the aptamer is continuously changed to adapt to the entry of the theophylline, and finally the stable state is achieved. At this time, the mixed aptamer-theophylline solution is added into deionized water, diluted to 100 μ L, and transferred to a 96-well plate to collect SERS signals. The final detection concentrations of the substances to be detected were all 10. mu.M, and the results are shown in FIG. 3. The characteristic peak of theophylline disappears after the theophylline is combined with the aptamer and is completely covered by the aptamer. The complex pattern was very similar to the aptamer pattern, only at 510,571,686,1295, and 1577cm-1The peaks at five positions are clearly different and can be considered to be caused by the conformational change of the aptamer.
SERS detection conditions: all spectra were acquired by a BWS415Raman spectrometer (B & W Tek, USA) instrument with an excitation wavelength of 785nm, laser power of 100mW, and integration time of 10 s.
Example 4: change of SERS spectrogram before and after theophylline and negative control NC reaction
And (3) weakly combining the randomly selected RNA sequence NC to the surface of the silver colloid under the same condition as the aptamer, then fully reacting with theophylline, and finally collecting the SERS spectrum. The results are shown in FIG. 4. As can be seen from fig. 4A, although both aptamers and NCs are nucleic acid sequences, SERS techniques can distinguish well between different RNA sequences. Meanwhile, since there is no affinity between theophylline and NC, theophylline does not interact with the aptamer when added to the aptamer solution, so that the conformation of NC does not change, so that the profile of the theophylline-NC mixture is almost the same as the profile of NC alone (see fig. 3d, 3 e).
SERS detection conditions were the same as in example 3.
Example 5: dynamic process of combining MD simulation theophylline and aptamer
The initialization of the simulation architecture is first established. Placing the theophylline and aptamer system in a water box with proper size (the distance from the surface of the compound to the boundary of the water box is
Figure BDA0002234382890000091
) And selecting SPC/E as a water model, and then ionizing the system. The force field parameter file for theophylline was generated by AmberTools. The system was then subjected to energy minimization and equilibrium simulations. Energy minimization Using the steepest descent algorithm, simulations were run at 500steps without constraints. The equilibrium simulation is divided into two steps: the temperature of the system is controlled to be increased from 0K to 300K in the first step, 10000steps are simulated in operation under the constraint condition, the temperature of the system is maintained to be 300K in the second step, and 10000steps are simulated in operation under the constraint condition. Finally, the balanced system is used to simulate 95ns (step size is 2fs) under the NPT ensemble. The pressure is controlled at 1.01atm and the temperature is controlled at 310K. Meanwhile, the RMSD (root-mean-square deviation) of the aptamer-theophylline molecular complex system along with the change of time is calculated to estimate the change degree of the conformation before and after the combination of the aptamer-theophylline molecular complex system and the theophylline molecular complex system. We also analyzed the conformational change process by intercepting conformational states at several different frame numbers, and the results are shown in fig. 4. When theophylline approaches to the aptamer, the aptamer allows theophylline to enter by changing the spatial conformation of the aptamer, and the conformation of the aptamer is continuously changed after the theophylline enters and reacts with certain basic groups on the aptamerAnd finally reaching the energy minimum state to maintain the stable existence of the complex.
Example 6: calculating the motion correlation coefficient of the aptamer and the main group on theophylline
And obtaining the PDB file of each frame by using gromacs. The centroid coordinates of each nucleotide and theophylline in each frame of the PDB file are written down, saved as — 'frame number' _ c. And respectively reading PDB files of each frame and the next frame of barycentric coordinates, and subtracting the barycentric coordinates of the previous frame from the next frame of barycentric coordinates of each nucleotide or theophylline to obtain the motion vector of the barycentric coordinates of each frame. Then, using numpy.corrcoef () command in python to obtain the correlation coefficient (pearson product moment correlation coefficient) of the small molecule centroid coordinate movement vector and each nucleotide centroid coordinate movement vector, and recording the correlation coefficient as a motion correlation coefficient. And averaging the motion correlation coefficient of each nucleotide and the small molecule in all the adjacent frames to obtain the average motion correlation coefficient. The kinetic correlation coefficients of 33 bases on the aptamer and N-1, N-3, N-7, N-9, C ═ O-2, C ═ O-6, CH3-1, CH3-3, the pyrimidine ring, and the imidazole ring on theophylline were calculated, respectively, to obtain the data of table 1, and the data of table 1 was converted into fig. 5. The closer the motion correlation coefficient is to 1, the closer the motion correlation coefficient is, the interaction may exist.
As can be seen from FIG. 5, the major groups or atoms on theophylline have high kinematic correlation with the bases C9, G11, C20, C21 and G25 on the aptamer, which indicates that when theophylline enters the inside of the aptamer, the bases on the aptamer react with theophylline, so that the conformation of the aptamer is changed to maintain the stability of the theophylline-aptamer complex.
TABLE 1 specific values for the kinematic correlation coefficient of 33 bases on aptamer RNA to the main atom or group on theophylline
Figure BDA0002234382890000111
While the preferred embodiments of the present invention have been described in detail, it will be understood by those skilled in the art that the invention is not limited thereto, and that various changes and modifications may be made without departing from the spirit of the invention, and the scope of the appended claims is to be accorded the full range of equivalents.
Sequence listing
<110> second military medical university of China people liberation army
<120> a method for rapidly and effectively detecting conformation change in the process of combining aptamer and ligand small molecule
<130>/
<160>2
<170>SIPOSequenceListing 1.0
<210>1
<211>33
<212>RNA
<213> Artificial sequence (Artificial)
<400>1
ggcgauacca gccgaaaggc ccuuggcagc guc 33
<210>2
<211>21
<212>RNA
<213> Artificial sequence (Artificial)
<400>2
uuguacuaca caaaaguacu g 21

Claims (10)

1. A method for rapidly and effectively detecting the conformational change in the binding process of an aptamer and a ligand small molecule is characterized by comprising the following steps:
the method comprises the following steps: measuring the affinity between the selected aptamer and the ligand small molecule by using a biological membrane interference technology;
step two: weakly combining the aptamer on an SERS substrate by a surface enhanced Raman spectroscopy technology, collecting spectrograms of the aptamer before and after the aptamer is combined with small molecules of the ligand, and determining the change of the conformation of the aptamer and the reason of the change caused by attribution according to the change of the aptamer before and after the SERS spectrogram;
step three: the dynamic process of combining the ligand and the aptamer is simulated by utilizing a molecular dynamics simulation means, the motion correlation coefficient of the aptamer and the main group on the ligand is calculated, the space change condition of the aptamer in the combining process is analyzed, and the reason of causing the conformation change is explained.
2. The method for rapid and efficient detection of conformational changes during aptamer-ligand small molecule binding according to claim 1, wherein the first step is: firstly, respectively preparing a ligand solution and an aptamer solution by using buffer solution, then respectively adding 200 mu L of the prepared aptamer solution, ligand solution and buffer solution into each reaction hole, sequentially immersing a chip connected with streptomycin into each reaction hole according to a set program, and totally going through five stages, wherein each stage takes 60s, and the method comprises the following steps: baseline equilibration, aptamer coupling, sensor equilibration, binding and dissociation, and then the aptamer-ligand affinity constants.
3. The method for rapidly and effectively detecting the conformational change during the binding process of an aptamer and a ligand small molecule according to claim 1, wherein the second step is: firstly, preparing a silver colloid solution by a Lee method, and concentrating the obtained silver colloid solution by about 60 times by a method of centrifuging and removing supernatant; adding 5 mu L of 1mM KI solution into 10 mu L of the concentrated silver colloid solution; to the solution was added 4. mu.L of 10mM MgSO4A solution; after the aptamer is weakly bonded to the surface of the silver colloid, adding a ligand solution in an equal proportion, adding deionized water into the mixed aptamer-ligand solution, diluting to 100 mu L, and transferring to a 96-well plate to collect SERS signals; the final detection concentration of the substance to be detected was 10. mu.M.
4. The method for rapidly and effectively detecting the conformational change in the process of binding an aptamer and a ligand small molecule according to claim 3, wherein the method for preparing the silver colloid solution by the Lee method comprises the following steps: dissolving 36mg of silver nitrate powder in 200mL of deionized water, heating and continuously stirring until the solution slightly boils, then adding 4mL of 1% sodium citrate solution, continuously heating and stirring for about 1h until the solution turns from colorless to grayish green, stopping heating, cooling to room temperature, and storing in dark place.
5. The method for rapid and efficient detection of conformational changes during the binding of aptamer and ligand small molecule according to claim 1, wherein in step three, the method for modeling the dynamic process of ligand binding to aptamer comprises: firstly, establishing initialization of a simulation system; placing the ligand and aptamer system in a water box with a proper size, selecting SPC/E as a water model, and then carrying out ionization treatment on the system; the force field parameter file of the ligand is generated by AmberTools; then, carrying out energy minimization and balance simulation on the system; the energy minimization uses a steepest descent algorithm, and the simulation is carried out for 500steps under the condition of no constraint; the equilibrium simulation is divided into two steps: the temperature of the system is controlled to be increased from 0K to 300K in the first step, 10000steps are simulated in operation under the constraint condition, the temperature of the system is maintained to be 300K in the second step, and 10000steps are simulated in operation under the constraint condition; finally, simulating 95ns (step length is 2fs) by using the balanced system under the NPT ensemble; controlling the pressure to be 1.01atm and the temperature to be 310K; meanwhile, calculating the RMSD value of the aptamer-ligand molecule complex system along with the change of time to estimate the change degree of the conformation before and after the combination of the aptamer-ligand molecule complex system and the ligand molecule complex system; the conformational change process is analyzed by intercepting conformational states of several different frames.
6. The method for rapidly and effectively detecting the conformational change during the binding process of an aptamer and a ligand small molecule according to claim 1, wherein in the third step, the method for calculating the motion correlation coefficient between the aptamer and a main group on the ligand comprises: adopting gromacs to obtain a PDB file of each frame; respectively reading PDB files of each frame and the mass center coordinate of the next frame, and subtracting the mass center coordinate of the previous frame from the mass center coordinate of the next frame of each nucleotide or theophylline to obtain a movement vector of the mass center coordinate of each frame; then, acquiring a micromolecule centroid coordinate moving vector and a Pearson product moment correlation coefficient of each nucleotide centroid coordinate moving vector by using a numpy. And averaging the motion correlation coefficient of each nucleotide and the small molecule in all the adjacent frames to obtain the average motion correlation coefficient.
7. The method for rapidly and effectively detecting the conformational change during the binding process of an aptamer and a ligand small molecule according to claim 1, wherein the ligand is theophylline, and the aptamer is an RNA sequence shown as SEQ ID No. 1.
8. The method for rapid and efficient detection of conformational changes during aptamer-ligand small molecule binding according to claim 7, wherein the first step is: buffer Tris-HCl buffer +10mM MgSO4Respectively preparing 10 mu M theophylline solution and 500nM aptamer RNA solution at pH 7.4, wherein all the RNA solutions are prepared as-is and stored in an ice box to prevent degradation; then, after the prepared aptamer solution and 200 μ L of theophylline are respectively added into each reaction hole, the chip connected with streptomycin is sequentially immersed into each reaction hole according to a set program, and five stages are carried out, wherein each stage takes 60s, and the method comprises the following steps: baseline balance, aptamer coupling, sensor balance, binding and dissociation; then the response value of the aptamer-theophylline can be obtained.
9. The method for rapidly and effectively detecting the conformational change during the binding process of an aptamer and a ligand small molecule according to claim 7, wherein the second step is: first, a silver colloid solution was prepared by Lee method, and the obtained silver colloid solution was concentrated by 60 times by centrifugation and supernatant removal, 5. mu.L of 1mM KI solution was added to 10. mu.L of the concentrated silver colloid solution, and 4. mu.L of 10mM MgSO 2 was added to the solution4A solution; after the aptamer is weakly combined on the surface of the silver colloid, 100 mu M theophylline solution is added in an equal ratio; adding deionized water into the mixed aptamer-theophylline solution, diluting to 100 μ L, and transferringMoving to a 96-well plate to collect SERS signals; the final detection concentration of the substance to be detected is 10 mu M; SERS detection conditions: all spectra were acquired by a BWS415Raman spectrometer with an excitation wavelength of 785nm, laser power of 100mW, and integration time of 10 s.
10. The method for rapid and efficient detection of conformational changes during aptamer-ligand small molecule binding according to claim 7, wherein the third step is:
(A) dynamic process of combining MD simulation theophylline and aptamer
Firstly, establishing initialization of a simulation system; placing the theophylline and aptamer system in a water box with proper size, wherein the distance from the surface of the compound to the boundary of the water box is
Figure FDA0002234382880000031
Selecting SPC/E as a water model, and then carrying out ionization treatment on the system; the force field parameter file of theophylline is generated by AmberTools; then, carrying out energy minimization and balance simulation on the system; the energy minimization uses a steepest descent algorithm, and the simulation is carried out for 500steps under the condition of no constraint; the equilibrium simulation is divided into two steps: the temperature of the system is controlled to be increased from 0K to 300K in the first step, 10000steps are simulated in operation under the constraint condition, the temperature of the system is maintained to be 300K in the second step, and 10000steps are simulated in operation under the constraint condition; finally, simulating 95ns by using the balanced system under the NPT ensemble, wherein the step length is 2 fs; controlling the pressure to be 1.01atm and the temperature to be 310K; calculating the RMSD value of the aptamer-theophylline molecular complex system along with the change of time to estimate the change degree of the conformation before and after the combination of the aptamer-theophylline molecular complex system and the theophylline molecular complex system; intercepting the conformational states of a plurality of different frames, and analyzing the conformational change process;
(B) calculating the motion correlation coefficient of the aptamer and the main group on theophylline
Adopting gromacs to obtain a PDB file of each frame; respectively reading PDB files of each frame and the mass center coordinate of the next frame, and subtracting the mass center coordinate of the previous frame from the mass center coordinate of the next frame of each nucleotide or theophylline to obtain a movement vector of the mass center coordinate of each frame; then, acquiring a micromolecule centroid coordinate moving vector and a Pearson product moment correlation coefficient of each nucleotide centroid coordinate moving vector by using a numpy. Averaging the motion correlation coefficients of each nucleotide and the small molecules in all adjacent frames to obtain an average motion correlation coefficient; the motion correlation coefficients of 33 bases on the aptamer and N-1, N-3, N-7, N-9, C ═ O-2, C ═ O-6, CH3-1, CH3-3, the pyrimidine ring and the imidazole ring on theophylline are calculated respectively, and the closer the motion correlation coefficient is to 1, the closer the motion correlation coefficient is, the closer the motion correlation between the two is, the certain interaction can exist.
CN201910978373.9A 2019-10-15 2019-10-15 Method for detecting conformational change in binding process of aptamer and ligand small molecule Active CN110849863B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910978373.9A CN110849863B (en) 2019-10-15 2019-10-15 Method for detecting conformational change in binding process of aptamer and ligand small molecule

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910978373.9A CN110849863B (en) 2019-10-15 2019-10-15 Method for detecting conformational change in binding process of aptamer and ligand small molecule

Publications (2)

Publication Number Publication Date
CN110849863A true CN110849863A (en) 2020-02-28
CN110849863B CN110849863B (en) 2020-11-24

Family

ID=69597621

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910978373.9A Active CN110849863B (en) 2019-10-15 2019-10-15 Method for detecting conformational change in binding process of aptamer and ligand small molecule

Country Status (1)

Country Link
CN (1) CN110849863B (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112034188A (en) * 2020-09-03 2020-12-04 山西农业大学 Method for detecting whether bovine CART active peptide is combined with bovine follicular particle cell membrane receptor
CN112986212A (en) * 2021-03-10 2021-06-18 中国人民解放军海军军医大学 Research method for interaction of G-quadruplex aptamer and small molecule
CN113495111A (en) * 2020-04-02 2021-10-12 北京化工大学 Method for representing binding affinity of aptamer and target molecule and application
CN113686818A (en) * 2021-09-01 2021-11-23 南开大学 Method for determining affinity of graphene oxide to chlorella extracellular polymeric substances by utilizing biofilm interference technology
CN115728284A (en) * 2022-10-28 2023-03-03 南京师范大学 Method for determining interaction between aptamer and small molecule target based on surface enhanced Raman spectroscopy

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001006257A8 (en) * 1999-07-16 2001-11-29 Univ Wm Marsh Rice Metal nanoshells for biosensing applications
CN102103086A (en) * 2009-12-16 2011-06-22 中国科学院理化技术研究所 Method for detecting single molecule of single silicon nanowire in real time based on surface enhanced raman scattering effect
WO2014093378A1 (en) * 2012-12-10 2014-06-19 Northeastern University Estrogen receptor imaging agents
CN106407740A (en) * 2016-09-05 2017-02-15 南京大学 Method for screening anti-androgen activity of flavonoid compounds based on molecular dynamics simulation
CN106932375A (en) * 2015-12-31 2017-07-07 北京大学 The bio-orthogonal Raman in-situ detection method of protein conformation change
CN109285584A (en) * 2018-09-03 2019-01-29 南京大学 Distinguish the building and application of substance androgen and antiandrogen effect model

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001006257A8 (en) * 1999-07-16 2001-11-29 Univ Wm Marsh Rice Metal nanoshells for biosensing applications
CN102103086A (en) * 2009-12-16 2011-06-22 中国科学院理化技术研究所 Method for detecting single molecule of single silicon nanowire in real time based on surface enhanced raman scattering effect
WO2014093378A1 (en) * 2012-12-10 2014-06-19 Northeastern University Estrogen receptor imaging agents
CN106932375A (en) * 2015-12-31 2017-07-07 北京大学 The bio-orthogonal Raman in-situ detection method of protein conformation change
CN106407740A (en) * 2016-09-05 2017-02-15 南京大学 Method for screening anti-androgen activity of flavonoid compounds based on molecular dynamics simulation
CN109285584A (en) * 2018-09-03 2019-01-29 南京大学 Distinguish the building and application of substance androgen and antiandrogen effect model

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ALVARO E. ALIAGA等: "SERS, Molecular Dynamics and Molecular Orbital Studies of the MRKDV Peptide on Silver and Membrane Surfaces", 《THE JOURNAL OF PHYSICAL CHEMISTRY C》 *
RIIKKA PELTOMAA等: "Optical Biosensors for Label-Free Detection of Small Molecules", 《SENSORS》 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113495111A (en) * 2020-04-02 2021-10-12 北京化工大学 Method for representing binding affinity of aptamer and target molecule and application
CN112034188A (en) * 2020-09-03 2020-12-04 山西农业大学 Method for detecting whether bovine CART active peptide is combined with bovine follicular particle cell membrane receptor
CN112034188B (en) * 2020-09-03 2023-10-20 山西农业大学 Method for detecting whether bovine CART active peptide is combined with bovine follicular granule cell membrane receptor
CN112986212A (en) * 2021-03-10 2021-06-18 中国人民解放军海军军医大学 Research method for interaction of G-quadruplex aptamer and small molecule
CN113686818A (en) * 2021-09-01 2021-11-23 南开大学 Method for determining affinity of graphene oxide to chlorella extracellular polymeric substances by utilizing biofilm interference technology
CN115728284A (en) * 2022-10-28 2023-03-03 南京师范大学 Method for determining interaction between aptamer and small molecule target based on surface enhanced Raman spectroscopy
CN115728284B (en) * 2022-10-28 2024-04-26 南京师范大学 Method for determining interaction between aptamer and small molecular target based on surface-enhanced Raman spectroscopy

Also Published As

Publication number Publication date
CN110849863B (en) 2020-11-24

Similar Documents

Publication Publication Date Title
CN110849863B (en) Method for detecting conformational change in binding process of aptamer and ligand small molecule
Lussier et al. Machine-learning-driven surface-enhanced Raman scattering optophysiology reveals multiplexed metabolite gradients near cells
Zhang et al. Single-molecule analysis of microRNA and logic operations using a smart plasmonic nanobiosensor
Wang et al. Advances in single cell Raman spectroscopy technologies for biological and environmental applications
Sindbert et al. Accurate distance determination of nucleic acids via Forster resonance energy transfer: implications of dye linker length and rigidity
Li et al. Label-free detection of miRNA using surface-enhanced Raman spectroscopy
Lu et al. Aptamer-based plasmonic sensor array for discrimination of proteins and cells with the naked eye
Liu et al. Sensitive and direct DNA mutation detection by surface-enhanced Raman spectroscopy using rational designed and tunable plasmonic nanostructures
Premasiri et al. Surface-enhanced Raman scattering of whole human blood, blood plasma, and red blood cells: cellular processes and bioanalytical sensing
Papadopoulou et al. Structure of adenine on metal nanoparticles: pH equilibria and formation of Ag+ complexes detected by surface-enhanced Raman spectroscopy
EP2773958B1 (en) A method of identifying an analyte in a biological sample
Treffer et al. Recent advances in single-molecule sequencing
Wei et al. Recent advances in single-cell ultra-trace analysis
Khoshbin et al. Recent advances in computational methods for biosensor design
CN104007268A (en) Preparation method and application of biosensor for detecting matrix metalloproteinase-2
Schürer et al. Fluorescence correlation spectroscopy as a new method for the investigation of aptamer/target interactions
Li et al. Pathogen identification: ultrasensitive nucleic acid detection via a dynamic DNA nanosystem-integrated ratiometric electrochemical sensing strategy
Negahdary et al. An aptasensing platform for detection of heat shock protein 70 kDa (HSP70) using a modified gold electrode with lady fern-like gold (LFG) nanostructure
Huo et al. Miniaturized DNA sequencers for personal use: Unreachable dreams or achievable goals
Hu et al. Polymerase-driven logic signal amplification for the detection of small extracellular vesicle surface proteins and the identification of breast cancer
Zhang et al. Large Laser Spot-Swift Mapping Surface-Enhanced Raman Scattering on Ag Nanoparticle Substrates for Liquid Analysis in Serum-Based Cancer Diagnosis
Severins et al. Exploring molecular biology in sequence space: the road to next-generation single-molecule biophysics
Huang et al. Iridium (III) solvent complex-based electrogenerated chemiluminescence and photoluminescence sensor array for the discrimination of bases in oligonucleotides
JP2010524459A (en) Nucleic acid chip for generating binding profile of unknown biomolecule and single-stranded nucleic acid, method for producing nucleic acid chip, and method for analyzing unknown biomolecule using nucleic acid chip
van Dongen et al. A multiplexable plasmonic hairpin-DNA sensor based on target-specific tether dynamics

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant